You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Clean Generator for Resilient Power
SBC: STEALTH POWER LLC Topic: A224016Redacted
SBIR Phase II 2022 Department of DefenseArmy -
The first clinical use of the BiVACOR Total Artificial Heart
SBC: BIVACOR INC Topic: NHLBISUMMARY/ABSTRACT Heart Failure (HF) is a devastating epidemic affecting more than 23 million patients worldwide; in the U.S. alone, 1,000,000 new cases are reported each year. While heart transplantation provides the best treatment option for many patients, less than 6,000 procedures take place globally each year. Consequently, it is estimated that 50,000 – 100,000 patients could immediately ben ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection
SBC: BASE PAIR BIOTECHNOLOGIES INC Topic: NIBIBProject Summary/Abstract The United States is experiencing an epidemic of unprecedented scope with heroin use resurging and a troubling pervasive increase in abuse of prescription opioids such as fentanyl, fentanyl derivatives, methadone, oxycodone and hydrocodone. More than 6 out of 10 drug overdoses are now opioid-related, resulting in ~90 deaths/day and a more than $75B/year economic impact. Ad ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant
SBC: Marker Therapeutics, Inc. Topic: NCIABSTRACT This Phase II application will advance MT-401, a novel multi-tumor associated antigen (mTAA)-specific T cell product for the treatment of acute myeloid leukemia (AML) and other cancers. In the USA, ~3,500 AML patients receive hematopoietic stem cell therapy (HSCT) every year, but overall survival remains lt30%, with an estimated median survival of lt1 year. Although AML is sensitive to im ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of a shelf-stable universal mucosal HA-vaccine for the prevention of influenza
SBC: TFF PHARMACEUTICALS, INC. Topic: NIAIDPROJECT SUMMARY TFF Pharmaceuticals (TFFP) is developing a shelf-stable thin-film freeze (TFF) dry powder universal flu vaccine. Commercialization of this product would provide the first vaccine that is at least 75% effective against symptomatic influenza virus infection, with the added benefit of easy delivery and storage at room temperature to facilitate broad, cost-effective distribution. With ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of a High Throughput Assay for Rapid Screening of Congenital Cytomegalovirus Infection using Dried Blood Spots
SBC: Microgen LLC Topic: NIDCDProject Summary Sensorineural hearing loss (SNHL), a condition where the inner ear cannot convert sound into nerve impulses to the brain, is the most common congenital disease. The leading cause of non-genetic SNHL is congenital cytomegalovirus (cCMV) infection, and the economic burden of SNHL and its detrimental effect on language development in the US is estimated at nearly $4 billion annually. ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
High-efficiency Purcell-enhanced mid-infrared light emitting diodes and their arrays
SBC: TRANSWAVE PHOTONICS, LLC Topic: N211021TransWave Photonics proposes to develop 1024 x 1024 light emitting diode (LED) arrays capable to produce >15% wall-plug efficiency based on successful demonstration of single Purcell LED devices developed in Phase I. We will optimize the LED band structure, pixel geometry, and fabrication steps of Purcell LEDs and implement them to achieve the target specifications. Then, 1024x1024 addressable Pur ...
SBIR Phase II 2023 Department of DefenseNavy -
Depleting autoantibodies for the treatment of autoimmunity
SBC: ASTERO ERADO INC Topic: NIAIDPROJECT SUMMARY/ABSTRACT The overall goal of this project is to develop a novel therapeutic for the treatment of primary (idiopathic) membranous nephropathy (MN). MN is a leading cause of nephrotic syndrome in adults and has a variable clinical course. About one third of patients enter spontaneous remission, whereas the remainder have persistent proteinuria that can lead to end stage renal disease ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Augmented Reality Training Tools with Realistic Animations and Voice Navigation on Tablet and AR Headset for Combat Casualty Care
SBC: SHARP VISION SOFTWARE LLC Topic: DHP163002Development of Augmented Reality (AR) training tools for combat casualty care with realistic animations and voice navigation capability on tablets and AR headset is proposed to enhance the tools that have already been developed during the Phase II effort on fasciotomy, cricothyroidotomy, and lateral canthotomy. Such enhancements are made possible by the recent advancement in both hardware and soft ...
SBIR Phase II 2023 Department of DefenseDefense Health Agency -
Software Toolset for Rapid Finite Element (FE) Mesh Generation of As-Built Large Laminated Composite Structural Components
SBC: NUMERICAL TECHNOLOGY COMPANY LLC Topic: N202103This effort will focus on developing effective tools enabling automatically building structured finite element (FE) mesh for as-built composite parts from X-ray Computed Tomography (CT) scan data that accurately captures performance-critical flaws in the form of the manufacturing defects. Such tools will fill a major technology gap in analysis-based assessment of residual capability and remaining ...
SBIR Phase II 2023 Department of DefenseNavy